The Clinical Impact of Transcatheter Arterial Chemoembolization (TACE)-Induced c-Met Upregulation on TACE Refractoriness in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

The Clinical Impact of Transcatheter Arterial Chemoembolization (TACE)-Induced c-Met Upregulation on TACE Refractoriness in Hepatocellular Carcinoma

Published:2016-01-02 Issue:6 Volume:61 Page:1572-1581
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Kajihara Jun,Tomimaru Yoshito,Eguchi Hidetoshi,Yamada Daisaku,Wada Hiroshi,Tomokuni Akira,Asaoka Tadafumi,Kawamoto Koichi,Marubashi Shigeru,Nagano Hiroaki,Umeshita Koji,Doki Yuichiro,Mori Masaki

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-015-4018-9.pdf

Reference48 articles.

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–750.

2. Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg. 2001;234:63–70.

3. Kudo M, Matsui O, Izumi N, et al. Transarterial chemoembolization failure/refractoriness: JSH-LCSGJ criteria 2014 update. Oncology. 2014;87:22–31.

4. Lencioni R. Chemoembolization in patients with hepatocellular carcinoma. Liver Cancer. 2012;1:41–50.

5. Camma C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology. 2002;224:47–54.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteoglycan-4 predicts good prognosis in patients with hepatocellular carcinoma receiving transcatheter arterial chemoembolization and inhibits cancer cell migration in vitro;Frontiers in Oncology;2022-11-11

2. Transcatheter arterial chemoembolization followed by surgical resection for hepatocellular carcinoma;Chinese Medical Journal;2021-09-28

3. Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems;Seminars in Liver Disease;2021-09-20

4. CT-Guided 125I Brachytherapy in the Treatment of Hepatocellular Carcinoma Refractory to Conventional Transarterial Chemoembolization: A Pilot Study;Cancer Management and Research;2021-04

5. Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2020-10-31